These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18446731)

  • 21. Methodological considerations for end-of-life research in patients with chronic kidney disease.
    Davidson SN; Murtagh FE; Higginson IJ
    J Nephrol; 2008; 21(3):268-82. PubMed ID: 18587713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why we need a health-related quality of life CPM.
    Stec P; Schatell D; Witten B
    Nephrol News Issues; 2008 Mar; 22(3):28-30, 35. PubMed ID: 18372678
    [No Abstract]   [Full Text] [Related]  

  • 23. How to support the patient with chronic disease. A philosophical point of view.
    von Engelhardt D
    J Nephrol; 2008; 21 Suppl 13():S24-9. PubMed ID: 18446729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative aspects of the cost/benefits ratio in dialysis-transplant].
    Guzzanti E; Picca S
    Minerva Chir; 1989 Feb; 44(4):793-800. PubMed ID: 2497406
    [No Abstract]   [Full Text] [Related]  

  • 25. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High societal costs of brain diseases. Extremely small resources allocated to research on prevention and treatment].
    Sobocki P; Allgulander C; Hillert J; Jönsson B
    Lakartidningen; 2007 May 14-29; 104(20-21):1590-4. PubMed ID: 17564267
    [No Abstract]   [Full Text] [Related]  

  • 28. Project Hope study looks at quality of life issues and economic implications of daily dialysis.
    Nephrol News Issues; 1999 Nov; 13(11):20, 24. PubMed ID: 10865621
    [No Abstract]   [Full Text] [Related]  

  • 29. [Quality of life of the elderly patient on dialysis].
    Lupo A; Trabucco G; Boaretti C; Rugiu C; Loschiavo C; Fontana L; Bravi E; Magalini A; Abaterusso C; DeBiase V; Gambaro G
    G Ital Nefrol; 2008; 25(6):708-12. PubMed ID: 19048572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of chronic kidney disease care in southeast Asia.
    Jha V
    Semin Nephrol; 2009 Sep; 29(5):487-96. PubMed ID: 19751894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infant treatment decisions: ethics and cost.
    Weber LJ
    Health Prog; 1984 Dec; 65(11):28-31. PubMed ID: 10310908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-morbidity and quality of life in chronic kidney disease patients.
    Mucsi I; Kovacs AZ; Molnar MZ; Novak M
    J Nephrol; 2008; 21 Suppl 13():S84-91. PubMed ID: 18446738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The marginal cost of satellite versus in-center hemodialysis.
    Soroka SD; Kiberd BA; Jacobs P
    Hemodial Int; 2005 Apr; 9(2):196-201. PubMed ID: 16191069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Audit on quality of life of patients with chronic kidney disease on dialysis and after transplant].
    Stratta P; Coppo R
    G Ital Nefrol; 2008; 25 Suppl 41():S45-8, discussion S48-57. PubMed ID: 18473319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perceived illness intrusion among patients on hemodialysis.
    Bapat U; Kedlaya PG;
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):386-91. PubMed ID: 19414939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney.
    Grima DT; Airia P; Attard C; Hutchison CA
    Curr Med Res Opin; 2011 Feb; 27(2):383-91. PubMed ID: 21175375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease in the United States: a public policy imperative.
    Rettig RA; Norris K; Nissenson AR
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1902-10. PubMed ID: 18922986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of government and competing priorities in minority populations and developing nations.
    Depine S
    Ethn Dis; 2009; 19(1 Suppl 1):S1-73-9. PubMed ID: 19484881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.